

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.62207796 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.59916857 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.51918176 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.37657053 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.33558050 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.01216796 |
| 7 | negative regulation of cell killing (GO:0031342) | 5.01216796 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.85550771 |
| 9 | type I interferon signaling pathway (GO:0060337) | 4.67760092 |
| 10 | cellular response to type I interferon (GO:0071357) | 4.67760092 |
| 11 | response to type I interferon (GO:0034340) | 4.64934248 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.37731771 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.34848377 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.34848377 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.34848377 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.34848377 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.34848377 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.34848377 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.30156260 |
| 20 | negative thymic T cell selection (GO:0045060) | 4.12663676 |
| 21 | negative T cell selection (GO:0043383) | 4.12314018 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 4.08869368 |
| 23 | detection of other organism (GO:0098543) | 4.05596470 |
| 24 | positive thymic T cell selection (GO:0045059) | 4.00022563 |
| 25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.96564876 |
| 26 | detection of bacterium (GO:0016045) | 3.92039153 |
| 27 | response to interleukin-15 (GO:0070672) | 3.89876031 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.86189645 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.84187530 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.83230220 |
| 31 | cellular response to interleukin-15 (GO:0071350) | 3.71939793 |
| 32 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.67544220 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 3.66856315 |
| 34 | T cell migration (GO:0072678) | 3.65741895 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.65477674 |
| 36 | leukocyte aggregation (GO:0070486) | 3.65310333 |
| 37 | response to interferon-alpha (GO:0035455) | 3.60452049 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.59328960 |
| 39 | detection of external biotic stimulus (GO:0098581) | 3.59069601 |
| 40 | neutrophil activation involved in immune response (GO:0002283) | 3.57784825 |
| 41 | B cell mediated immunity (GO:0019724) | 3.54685888 |
| 42 | positive T cell selection (GO:0043368) | 3.52216547 |
| 43 | detection of molecule of bacterial origin (GO:0032490) | 3.48573179 |
| 44 | regulation of B cell differentiation (GO:0045577) | 3.43321554 |
| 45 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.41530031 |
| 46 | regulation of T cell tolerance induction (GO:0002664) | 3.41296675 |
| 47 | response to peptidoglycan (GO:0032494) | 3.40157744 |
| 48 | thymic T cell selection (GO:0045061) | 3.40133421 |
| 49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39121276 |
| 50 | response to host immune response (GO:0052572) | 3.39121276 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.38780151 |
| 52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.33828303 |
| 53 | positive regulation of interferon-alpha production (GO:0032727) | 3.33798543 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.33514290 |
| 55 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.33025602 |
| 56 | T cell selection (GO:0045058) | 3.31160128 |
| 57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28443499 |
| 58 | response to interferon-beta (GO:0035456) | 3.27709750 |
| 59 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.22819332 |
| 60 | response to host defenses (GO:0052200) | 3.22794996 |
| 61 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.22794996 |
| 62 | response to host (GO:0075136) | 3.22794996 |
| 63 | regulation of antigen processing and presentation (GO:0002577) | 3.22482330 |
| 64 | regulation of tolerance induction (GO:0002643) | 3.20532260 |
| 65 | regulation of interferon-alpha production (GO:0032647) | 3.16418863 |
| 66 | * negative regulation of viral genome replication (GO:0045071) | 3.13231158 |
| 67 | detection of biotic stimulus (GO:0009595) | 3.10695398 |
| 68 | myeloid cell activation involved in immune response (GO:0002275) | 3.10666847 |
| 69 | germinal center formation (GO:0002467) | 3.08308208 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07874061 |
| 71 | cellular extravasation (GO:0045123) | 3.06199751 |
| 72 | cellular response to interferon-gamma (GO:0071346) | 3.05852377 |
| 73 | defense response to protozoan (GO:0042832) | 3.05088580 |
| 74 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03324100 |
| 75 | NIK/NF-kappaB signaling (GO:0038061) | 3.02957893 |
| 76 | positive regulation of antigen processing and presentation (GO:0002579) | 3.02336507 |
| 77 | positive regulation of tolerance induction (GO:0002645) | 3.00955061 |
| 78 | regulation of regulatory T cell differentiation (GO:0045589) | 3.00455929 |
| 79 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96698027 |
| 80 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.93486967 |
| 81 | response to muramyl dipeptide (GO:0032495) | 2.91053781 |
| 82 | tolerance induction (GO:0002507) | 2.90761639 |
| 83 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.89343931 |
| 84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89173103 |
| 85 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.88403844 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87194131 |
| 87 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87105041 |
| 88 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.86830140 |
| 89 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.86687867 |
| 90 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.86374126 |
| 91 | microglial cell activation (GO:0001774) | 2.86105353 |
| 92 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84365393 |
| 93 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.83101879 |
| 94 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.83101879 |
| 95 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.82267760 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.82267760 |
| 97 | T cell costimulation (GO:0031295) | 2.81378921 |
| 98 | response to interferon-gamma (GO:0034341) | 2.78316042 |
| 99 | response to protozoan (GO:0001562) | 2.77547964 |
| 100 | lymphocyte costimulation (GO:0031294) | 2.77059448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.23498717 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.52238757 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.74544988 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.55451749 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.48783383 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.11889307 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.57449667 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.24410039 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.15306323 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.03358917 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.00697200 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.00500774 |
| 13 | * MYB_26560356_Chip-Seq_TH2_Human | 2.82731840 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.76483412 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.71404075 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68342235 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.68025454 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55006920 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.52785081 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.43612441 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31114379 |
| 22 | * MYB_26560356_Chip-Seq_TH1_Human | 2.26005443 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.24754293 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23640927 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23155848 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.20581893 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.11170156 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09178806 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06233297 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05825802 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03148035 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.97236495 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.95215779 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92343741 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89457576 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.87134982 |
| 37 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.86455111 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84311535 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83200110 |
| 40 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.79971236 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71867687 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71517041 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65963189 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60519423 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59296706 |
| 46 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.56813095 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.53260378 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51899825 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47361911 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43127421 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34625945 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33674488 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33618907 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30935258 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30399297 |
| 56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27219009 |
| 57 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22392199 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21257156 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21205245 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.20413160 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20088883 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17323926 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17171014 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15333745 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14209484 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12314957 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08428199 |
| 68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07488871 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06773011 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06174994 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05062522 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03944988 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01662995 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99228822 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98410629 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95777966 |
| 77 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95121782 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94876677 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94613274 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92795989 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92357815 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88335506 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87245438 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85986226 |
| 85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85224177 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83584372 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79180411 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78826633 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.75549062 |
| 90 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.75309942 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.72947999 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71679205 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.70652659 |
| 94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.70652659 |
| 95 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.67321779 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66966168 |
| 97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65218869 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.65171965 |
| 99 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64277867 |
| 100 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63320967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.34211934 |
| 2 | MP0003724_increased_susceptibility_to | 4.01965708 |
| 3 | MP0005671_abnormal_response_to | 3.48199780 |
| 4 | MP0003436_decreased_susceptibility_to | 3.29822280 |
| 5 | MP0000685_abnormal_immune_system | 3.18156669 |
| 6 | MP0001800_abnormal_humoral_immune | 3.02121697 |
| 7 | MP0005387_immune_system_phenotype | 3.02108814 |
| 8 | MP0001790_abnormal_immune_system | 3.02108814 |
| 9 | MP0009785_altered_susceptibility_to | 2.99126122 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.97964179 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.96430293 |
| 12 | MP0003303_peritoneal_inflammation | 2.77928762 |
| 13 | MP0005025_abnormal_response_to | 2.63432880 |
| 14 | MP0002723_abnormal_immune_serum | 2.58516487 |
| 15 | MP0002419_abnormal_innate_immunity | 2.55706066 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.55308114 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.51274098 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.44625611 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.43862118 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.42381026 |
| 21 | MP0001819_abnormal_immune_cell | 2.41309452 |
| 22 | MP0006082_CNS_inflammation | 2.27957563 |
| 23 | MP0002398_abnormal_bone_marrow | 2.00714699 |
| 24 | MP0002405_respiratory_system_inflammati | 1.99306925 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.98914265 |
| 26 | MP0000716_abnormal_immune_system | 1.91260671 |
| 27 | MP0004947_skin_inflammation | 1.89253092 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.89033226 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.83521427 |
| 30 | MP0002006_tumorigenesis | 1.78725652 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.74378789 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.72874340 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.71408948 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.68689261 |
| 35 | MP0004381_abnormal_hair_follicle | 1.63177916 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.60212916 |
| 37 | MP0002722_abnormal_immune_system | 1.59130828 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.56571208 |
| 39 | MP0002429_abnormal_blood_cell | 1.54500946 |
| 40 | MP0008260_abnormal_autophagy | 1.54256595 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.50918126 |
| 42 | MP0003828_pulmonary_edema | 1.50225264 |
| 43 | MP0006054_spinal_hemorrhage | 1.49270758 |
| 44 | MP0000858_altered_metastatic_potential | 1.43577593 |
| 45 | MP0001853_heart_inflammation | 1.40434297 |
| 46 | MP0003866_abnormal_defecation | 1.34736073 |
| 47 | MP0003448_altered_tumor_morphology | 1.33295054 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.32888009 |
| 49 | MP0008469_abnormal_protein_level | 1.32773525 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.28181447 |
| 51 | MP0009764_decreased_sensitivity_to | 1.27864208 |
| 52 | MP0001873_stomach_inflammation | 1.27189769 |
| 53 | MP0002933_joint_inflammation | 1.25704764 |
| 54 | MP0003045_fibrosis | 1.25494422 |
| 55 | MP0001851_eye_inflammation | 1.24389408 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 1.23950856 |
| 57 | MP0005310_abnormal_salivary_gland | 1.23064516 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.18900834 |
| 59 | MP0009278_abnormal_bone_marrow | 1.17634630 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.12932044 |
| 61 | MP0004808_abnormal_hematopoietic_stem | 1.11549169 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.05256632 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.05256632 |
| 64 | MP0005451_abnormal_body_composition | 1.04151237 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.04125334 |
| 66 | MP0004883_abnormal_blood_vessel | 1.01765843 |
| 67 | MP0005164_abnormal_response_to | 1.01520616 |
| 68 | MP0003075_altered_response_to | 1.01182227 |
| 69 | MP0001958_emphysema | 0.99824569 |
| 70 | MP0005166_decreased_susceptibility_to | 0.99435523 |
| 71 | MP0003091_abnormal_cell_migration | 0.99093314 |
| 72 | MP0002132_abnormal_respiratory_system | 0.97973260 |
| 73 | MP0003183_abnormal_peptide_metabolism | 0.97606245 |
| 74 | MP0000343_altered_response_to | 0.93922898 |
| 75 | MP0009763_increased_sensitivity_to | 0.93677659 |
| 76 | MP0005390_skeleton_phenotype | 0.92353260 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.92177446 |
| 78 | MP0000569_abnormal_digit_pigmentation | 0.90099085 |
| 79 | MP0003279_aneurysm | 0.87834831 |
| 80 | MP0005275_abnormal_skin_tensile | 0.83280955 |
| 81 | MP0000249_abnormal_blood_vessel | 0.78691613 |
| 82 | MP0005023_abnormal_wound_healing | 0.78479016 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.77882911 |
| 84 | MP0004510_myositis | 0.74564379 |
| 85 | MP0003795_abnormal_bone_structure | 0.72266669 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.72204682 |
| 87 | MP0003806_abnormal_nucleotide_metabolis | 0.71630267 |
| 88 | MP0002009_preneoplasia | 0.71255131 |
| 89 | MP0005165_increased_susceptibility_to | 0.67619308 |
| 90 | MP0001663_abnormal_digestive_system | 0.66369603 |
| 91 | MP0008004_abnormal_stomach_pH | 0.66066060 |
| 92 | MP0000604_amyloidosis | 0.63018755 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.60533044 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.55214440 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.55194634 |
| 96 | MP0000371_diluted_coat_color | 0.54938941 |
| 97 | MP0000490_abnormal_crypts_of | 0.54378527 |
| 98 | MP0002060_abnormal_skin_morphology | 0.54100980 |
| 99 | MP0001542_abnormal_bone_strength | 0.53756169 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.53000355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.83943926 |
| 2 | Myositis (HP:0100614) | 4.50121828 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.46123386 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.45685355 |
| 5 | T lymphocytopenia (HP:0005403) | 4.40395903 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.35697209 |
| 7 | Abnormality of T cell number (HP:0011839) | 4.31098855 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.26070397 |
| 9 | Orchitis (HP:0100796) | 4.17307256 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.15438851 |
| 11 | Meningitis (HP:0001287) | 4.03020661 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.97171692 |
| 13 | Optic neuritis (HP:0100653) | 3.97171692 |
| 14 | Recurrent viral infections (HP:0004429) | 3.93464299 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.89748526 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.89748526 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.77907539 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 3.70560264 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.65990915 |
| 20 | Vasculitis (HP:0002633) | 3.64485539 |
| 21 | Agammaglobulinemia (HP:0004432) | 3.54361338 |
| 22 | Recurrent skin infections (HP:0001581) | 3.51637766 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.50284296 |
| 24 | Abnormality of T cells (HP:0002843) | 3.45837555 |
| 25 | Stomatitis (HP:0010280) | 3.45730783 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.43252512 |
| 27 | Recurrent bronchitis (HP:0002837) | 3.42361647 |
| 28 | Pulmonary infiltrates (HP:0002113) | 3.40976239 |
| 29 | Increased IgE level (HP:0003212) | 3.32042622 |
| 30 | Autoimmune hemolytic anemia (HP:0001890) | 3.31350785 |
| 31 | Encephalitis (HP:0002383) | 3.26808922 |
| 32 | Cellulitis (HP:0100658) | 3.14453589 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13734804 |
| 34 | Increased IgM level (HP:0003496) | 3.13349075 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 3.10260962 |
| 36 | Granulocytopenia (HP:0001913) | 3.02693954 |
| 37 | Hemoptysis (HP:0002105) | 3.02224477 |
| 38 | Eosinophilia (HP:0001880) | 3.01549257 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99334401 |
| 40 | Obstructive lung disease (HP:0006536) | 2.99334401 |
| 41 | Chest pain (HP:0100749) | 2.98182751 |
| 42 | Abnormality of B cell number (HP:0010975) | 2.97234565 |
| 43 | Urticaria (HP:0001025) | 2.93566702 |
| 44 | Gingivitis (HP:0000230) | 2.89559141 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.85964843 |
| 46 | Pustule (HP:0200039) | 2.85762817 |
| 47 | Leukocytosis (HP:0001974) | 2.85696550 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.84508004 |
| 49 | IgG deficiency (HP:0004315) | 2.83711844 |
| 50 | B lymphocytopenia (HP:0010976) | 2.79525123 |
| 51 | Hypergammaglobulinemia (HP:0010702) | 2.74614179 |
| 52 | Gastrointestinal stroma tumor (HP:0100723) | 2.71380881 |
| 53 | Osteomyelitis (HP:0002754) | 2.63368951 |
| 54 | Arterial thrombosis (HP:0004420) | 2.60818107 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.58913474 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57262831 |
| 57 | Lymphopenia (HP:0001888) | 2.56296148 |
| 58 | Abnormality of eosinophils (HP:0001879) | 2.53145985 |
| 59 | IgM deficiency (HP:0002850) | 2.51673577 |
| 60 | Severe combined immunodeficiency (HP:0004430) | 2.50580367 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.47930631 |
| 62 | Colitis (HP:0002583) | 2.47780120 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.46882184 |
| 64 | Peritonitis (HP:0002586) | 2.45928061 |
| 65 | Chronic diarrhea (HP:0002028) | 2.43044195 |
| 66 | Papilloma (HP:0012740) | 2.42707845 |
| 67 | Verrucae (HP:0200043) | 2.42707845 |
| 68 | Gingival bleeding (HP:0000225) | 2.38670072 |
| 69 | Epistaxis (HP:0000421) | 2.36896886 |
| 70 | Pulmonary embolism (HP:0002204) | 2.34654571 |
| 71 | Abnormality of the prostate (HP:0008775) | 2.34282115 |
| 72 | Gangrene (HP:0100758) | 2.29537143 |
| 73 | Skin ulcer (HP:0200042) | 2.28575271 |
| 74 | Abnormality of the pleura (HP:0002103) | 2.27425874 |
| 75 | Abnormality of the peritoneum (HP:0002585) | 2.24999205 |
| 76 | Sepsis (HP:0100806) | 2.24359519 |
| 77 | Chronic otitis media (HP:0000389) | 2.18282340 |
| 78 | Spondylolisthesis (HP:0003302) | 2.16055429 |
| 79 | Skin rash (HP:0000988) | 2.14840449 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.14452367 |
| 81 | Viral hepatitis (HP:0006562) | 2.11764277 |
| 82 | Emphysema (HP:0002097) | 2.11716181 |
| 83 | Combined immunodeficiency (HP:0005387) | 2.08148748 |
| 84 | Glomerulopathy (HP:0100820) | 2.06959677 |
| 85 | Thyroiditis (HP:0100646) | 2.06761303 |
| 86 | Lymphoma (HP:0002665) | 2.04428200 |
| 87 | IgA deficiency (HP:0002720) | 2.04209560 |
| 88 | Recurrent lower respiratory tract infections (HP:0002783) | 2.02957413 |
| 89 | Fatigue (HP:0012378) | 2.02367983 |
| 90 | Restrictive lung disease (HP:0002091) | 2.01711205 |
| 91 | Recurrent pneumonia (HP:0006532) | 1.99841498 |
| 92 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98561675 |
| 93 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98561675 |
| 94 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98561675 |
| 95 | Premature loss of primary teeth (HP:0006323) | 1.96811233 |
| 96 | Hypoplasia of the thymus (HP:0000778) | 1.91852113 |
| 97 | Hypoproteinemia (HP:0003075) | 1.91817988 |
| 98 | Prostate neoplasm (HP:0100787) | 1.88801884 |
| 99 | Recurrent sinusitis (HP:0011108) | 1.88599584 |
| 100 | Abnormality of the pericardium (HP:0001697) | 1.88543928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.07356120 |
| 2 | RIPK4 | 3.67563006 |
| 3 | TYK2 | 3.25818781 |
| 4 | TXK | 2.76718642 |
| 5 | MAP3K14 | 2.74299491 |
| 6 | BLK | 2.64812407 |
| 7 | ERN1 | 2.62662724 |
| 8 | JAK3 | 2.58218549 |
| 9 | JAK1 | 2.48752144 |
| 10 | KIT | 2.40353236 |
| 11 | FES | 2.34308952 |
| 12 | IKBKE | 2.31848409 |
| 13 | CSK | 2.30437037 |
| 14 | PRPF4B | 2.26015251 |
| 15 | ZAP70 | 2.11945185 |
| 16 | IRAK4 | 2.02619396 |
| 17 | MAP3K13 | 1.98599229 |
| 18 | SYK | 1.98007110 |
| 19 | BTK | 1.96085990 |
| 20 | TBK1 | 1.89422347 |
| 21 | SIK3 | 1.88970274 |
| 22 | TAOK3 | 1.78543610 |
| 23 | FGFR4 | 1.71260419 |
| 24 | MAP2K3 | 1.67908490 |
| 25 | MAP3K3 | 1.60427989 |
| 26 | ITK | 1.59972977 |
| 27 | HCK | 1.58680129 |
| 28 | FGFR3 | 1.51392438 |
| 29 | CSF1R | 1.50912796 |
| 30 | TEC | 1.50165202 |
| 31 | GRK6 | 1.46662953 |
| 32 | NLK | 1.40728290 |
| 33 | EPHB1 | 1.40607217 |
| 34 | LYN | 1.37809516 |
| 35 | BMPR2 | 1.37764032 |
| 36 | LCK | 1.36301344 |
| 37 | TGFBR2 | 1.35999287 |
| 38 | IKBKB | 1.31036744 |
| 39 | TNK2 | 1.20563183 |
| 40 | JAK2 | 1.19809713 |
| 41 | KDR | 1.16917547 |
| 42 | STK10 | 1.09962442 |
| 43 | PIK3CG | 1.01785632 |
| 44 | FGR | 0.96726786 |
| 45 | MAPK7 | 0.94443927 |
| 46 | MARK3 | 0.94324572 |
| 47 | NEK9 | 0.92944772 |
| 48 | EIF2AK3 | 0.87459405 |
| 49 | MATK | 0.87109606 |
| 50 | SMG1 | 0.81943783 |
| 51 | TRPM7 | 0.81082037 |
| 52 | MAPK11 | 0.79555716 |
| 53 | IRAK1 | 0.76858045 |
| 54 | PRKCQ | 0.73899041 |
| 55 | TESK2 | 0.73721847 |
| 56 | CDC42BPA | 0.73240754 |
| 57 | MAP3K1 | 0.71828219 |
| 58 | LRRK2 | 0.67655134 |
| 59 | CDK4 | 0.65028545 |
| 60 | HIPK2 | 0.64921766 |
| 61 | GRK7 | 0.61062447 |
| 62 | EPHA3 | 0.59366751 |
| 63 | MAP3K6 | 0.57608114 |
| 64 | MAPKAPK2 | 0.56682772 |
| 65 | MAP3K10 | 0.56351070 |
| 66 | MAPK12 | 0.53770700 |
| 67 | PTK2B | 0.53301385 |
| 68 | PDK1 | 0.52807684 |
| 69 | CLK1 | 0.52299427 |
| 70 | MAP3K11 | 0.51624918 |
| 71 | CDK6 | 0.51102626 |
| 72 | YES1 | 0.50816954 |
| 73 | PIM1 | 0.47100436 |
| 74 | PRKD2 | 0.45656364 |
| 75 | FYN | 0.45598781 |
| 76 | TAOK2 | 0.43611342 |
| 77 | ABL1 | 0.42532371 |
| 78 | TIE1 | 0.41969720 |
| 79 | SCYL2 | 0.41532602 |
| 80 | MELK | 0.41512095 |
| 81 | DDR2 | 0.40998909 |
| 82 | CAMKK2 | 0.40633684 |
| 83 | IRAK3 | 0.40563849 |
| 84 | MAPKAPK3 | 0.40115769 |
| 85 | CHUK | 0.38873791 |
| 86 | PDGFRB | 0.37996670 |
| 87 | RIPK1 | 0.36956502 |
| 88 | MAP3K2 | 0.36647522 |
| 89 | MAP3K7 | 0.32379806 |
| 90 | MAPK4 | 0.30181858 |
| 91 | MOS | 0.28524626 |
| 92 | PDPK1 | 0.28257733 |
| 93 | MARK2 | 0.27913563 |
| 94 | PRKCD | 0.27537673 |
| 95 | MAP3K5 | 0.26696546 |
| 96 | KSR2 | 0.26674028 |
| 97 | TGFBR1 | 0.26432515 |
| 98 | EGFR | 0.26425503 |
| 99 | IGF1R | 0.26225660 |
| 100 | CDK12 | 0.25533934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.42441829 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.30373754 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.24319210 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.09536111 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81164861 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.65811702 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.55768533 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.55514579 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53717532 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.40672471 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.39621694 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.24783726 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.22030740 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14963699 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06502073 |
| 16 | Viral myocarditis_Homo sapiens_hsa05416 | 2.05220638 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.03945689 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95367034 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89835530 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.86396378 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.79076045 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.76940641 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.73761136 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69714238 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.67729060 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.66549232 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54505925 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48852198 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45441009 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42906546 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41895601 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31145460 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.26924925 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24855942 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24661597 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.16036556 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15152082 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 1.14491252 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13651748 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10077043 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.09359747 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.08467483 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07768048 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.04990944 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03733876 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.01440313 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 0.98969748 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95699211 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.95633146 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95318501 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93214515 |
| 52 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91675513 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88557784 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85315750 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83488137 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.81665148 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79408374 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75325360 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72923493 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66121225 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65988019 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60772972 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57783144 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.56620082 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56480334 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55706894 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.53572191 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.53009920 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52920521 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52595808 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52344523 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50885548 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50803887 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46340840 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42041857 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40947684 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.39673837 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38541096 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37745641 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36153230 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35436323 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31585110 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.31312362 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30494366 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30454431 |
| 86 | Bladder cancer_Homo sapiens_hsa05219 | 0.29676338 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29268277 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.28991243 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.28758111 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27831302 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26623620 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26604978 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26245559 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.22423587 |
| 95 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22193551 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21010100 |
| 97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.20736061 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19489767 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19453547 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19031433 |

